In TME, Treg cells induce immunosuppressive effects, which predominantly maintained by TCR signaling266 to inhibit tumor regression by diverse pathways 267, 268 In addition to TCR signaling, CD25 can induce STAT5 activation to maintain the suppressive function of Treg cells. This evidence concerns the gene IL2RA and neoplasm.